Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
3d
StudyFinds on MSNJournavx: What to know about new FDA-approved non-opioid pain medicationIntroducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results